tetano
Editor, Senior Moderator
Mol Syst Biol
. 2022 Feb;18(2):e10673.
doi: 10.15252/msb.202110673.
High diversity in Delta variant across countries revealed by genome-wide analysis of SARS-CoV-2 beyond the Spike protein
Rohit Suratekar[SUP] #[/SUP][SUP] 1 [/SUP], Pritha Ghosh[SUP] #[/SUP][SUP] 1 [/SUP], Michiel J M Niesen[SUP] 2 [/SUP], Gregory Donadio[SUP] 2 [/SUP], Praveen Anand[SUP] 1 [/SUP], Venky Soundararajan[SUP] 1 2 [/SUP], A J Venkatakrishnan[SUP] 2 [/SUP]
Affiliations
Abstract
The highly contagious Delta variant of SARS-CoV-2 has become a prevalent strain globally and poses a public health challenge around the world. While there has been extensive focus on understanding the amino acid mutations in the Delta variant's Spike protein, the mutational landscape of the rest of the SARS-CoV-2 proteome (25 proteins) remains poorly understood. To this end, we performed a systematic analysis of mutations in all the SARS-CoV-2 proteins from nearly 2 million SARS-CoV-2 genomes from 176 countries/territories. Six highly prevalent missense mutations in the viral life cycle-associated Membrane (I82T), Nucleocapsid (R203M, D377Y), NS3 (S26L), and NS7a (V82A, T120I) proteins are almost exclusive to the Delta variant compared to other variants of concern (mean prevalence across genomes: Delta = 99.74%, Alpha = 0.06%, Beta = 0.09%, and Gamma = 0.22%). Furthermore, we find that the Delta variant harbors a more diverse repertoire of mutations across countries compared to the previously dominant Alpha variant. Overall, our study underscores the high diversity of the Delta variant between countries and identifies a list of amino acid mutations in the Delta variant's proteome for probing the mechanistic basis of pathogenic features such as high viral loads, high transmissibility, and reduced susceptibility against neutralization by vaccines.
Keywords: Delta variant; SARS-CoV-2; coronavirus; mutations; proteome.
. 2022 Feb;18(2):e10673.
doi: 10.15252/msb.202110673.
High diversity in Delta variant across countries revealed by genome-wide analysis of SARS-CoV-2 beyond the Spike protein
Rohit Suratekar[SUP] #[/SUP][SUP] 1 [/SUP], Pritha Ghosh[SUP] #[/SUP][SUP] 1 [/SUP], Michiel J M Niesen[SUP] 2 [/SUP], Gregory Donadio[SUP] 2 [/SUP], Praveen Anand[SUP] 1 [/SUP], Venky Soundararajan[SUP] 1 2 [/SUP], A J Venkatakrishnan[SUP] 2 [/SUP]
Affiliations
- PMID: 35156767
- DOI: 10.15252/msb.202110673
Abstract
The highly contagious Delta variant of SARS-CoV-2 has become a prevalent strain globally and poses a public health challenge around the world. While there has been extensive focus on understanding the amino acid mutations in the Delta variant's Spike protein, the mutational landscape of the rest of the SARS-CoV-2 proteome (25 proteins) remains poorly understood. To this end, we performed a systematic analysis of mutations in all the SARS-CoV-2 proteins from nearly 2 million SARS-CoV-2 genomes from 176 countries/territories. Six highly prevalent missense mutations in the viral life cycle-associated Membrane (I82T), Nucleocapsid (R203M, D377Y), NS3 (S26L), and NS7a (V82A, T120I) proteins are almost exclusive to the Delta variant compared to other variants of concern (mean prevalence across genomes: Delta = 99.74%, Alpha = 0.06%, Beta = 0.09%, and Gamma = 0.22%). Furthermore, we find that the Delta variant harbors a more diverse repertoire of mutations across countries compared to the previously dominant Alpha variant. Overall, our study underscores the high diversity of the Delta variant between countries and identifies a list of amino acid mutations in the Delta variant's proteome for probing the mechanistic basis of pathogenic features such as high viral loads, high transmissibility, and reduced susceptibility against neutralization by vaccines.
Keywords: Delta variant; SARS-CoV-2; coronavirus; mutations; proteome.